(Q34901966)

5 August 2017

9 references

19 March 2019

22 March 2019

17 June 2019

17 September 2019

2 October 2019

7 November 2019

5 December 2020

20 January 2021

1 May 2021

Mechanism of action of the new anti-ischemia drug ranolazine (English)

1 reference

5 August 2017

main subject

coronary artery disease

3 references

19 March 2019

22 March 2019

17 June 2019

heterocyclic compound

1 reference

17 September 2019

6 references

17 September 2019

2 October 2019

7 November 2019

5 December 2020

20 January 2021

1 May 2021

1 reference

2 October 2019

1 reference

7 November 2019

1 reference

7 November 2019

1 reference

5 December 2020

1 reference

20 January 2021

1 reference

1 May 2021

G Hasenfuss

1

1 reference

5 August 2017

L S Maier

series ordinal

2

1 reference

5 August 2017

publication date

28 November 2007

1 reference

Clinical Research in Cardiology

5 August 2017

1 April 2008

9 references

19 March 2019

22 March 2019

17 June 2019

17 September 2019

2 October 2019

7 November 2019

5 December 2020

20 January 2021

1 May 2021

8 references

5 August 2017

17 June 2019

17 September 2019

2 October 2019

7 November 2019

5 December 2020

20 January 2021

1 May 2021

97

1 reference

5 August 2017

issue

4

1 reference

5 August 2017

page(s)

222-226

1 reference

Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085780

Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na+ channels

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085780

Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085780

Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085780

Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085780

Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085780

Defective cardiac ion channels: from mutations to clinical syndromes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085780

Rate dependence of [Na+]i and contractility in nonfailing and failing human myocardium

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085780

Perfusion-contraction match and mismatch

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085780

Hypoxia increases persistent sodium current in rat ventricular myocytes.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085780

Inward sodium current at resting potentials in single cardiac myocytes induced by the ischemic metabolite lysophosphatidylcholine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085780

Ionic mechanism of the effects of hydrogen peroxide in rat ventricular myocytes.

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00392-007-0612-Y

Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085780

Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085780

Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085780

Antiarrhythmic effects of ranolazine in a guinea pig in vitro model of long-QT syndrome

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085780

Palmitoyl carnitine modifies sodium currents and induces transient inward current in ventricular myocytes.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085780

Cardioprotective effects of ranolazine (RS-43285) in the isolated perfused rabbit heart.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085780

A controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agents. Ranolazine Study Group

26 October 2018

1 reference

12 December 2020

Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European society of cardiology

1 reference

12 December 2020

Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less

1 reference

12 December 2020

Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem

1 reference

12 December 2020

Effects of ranolazine on left ventricular regional diastolic function in patients with ischemic heart disease

1 reference

12 December 2020

Assessment of reverse use-dependent blocking actions of class III antiarrhythmic drugs by 24-hour Holter electrocardiography

1 reference

12 December 2020

Frequency-dependence of myocardial energetics in failing human myocardium as quantified by a new method for the measurement of oxygen consumption in muscle strip preparations

1 reference

12 December 2020

10.1007/S00392-007-0612-Y

Identifiers

DOI

1 reference

5 August 2017

1 reference

5 August 2017

1 reference